The most recent insider transaction at Oryzon Genomics SA occurred on September 21, 2022, when a Director of Business Development sold 36,900 shares for approximately $84,870. Prior to this, significant sell-offs were noted in early 2021 and late 2020 by other directors, totaling over 1.5 million shares.
